期刊文献+

NF-κ Bp65基因siRNA腺病毒载体的构建及其对EOMA细胞的影响

Construction of An Adenovirus Vector Encoding NF-κ Bp65 siRNA and Its Expression in EOMA Cells
下载PDF
导出
摘要 目的构建含NF-κ Bp65基因siRNA腺病毒载体,并研究其对小鼠血管瘤细胞EOMA中NF-κ Bp65基因表达的影响。方法首先构建含有NF-κ Bp65 shRNA的人H1启动子真核表达载体pSuperH1/shp65,利用NotⅠ与SalⅠ双酶切将人H1载体启动子和NF-κ Bp65 shRNA序列亚克隆至经相同酶切的腺病毒穿梭质粒pShuttle中,形成转移质粒pShuttle-H1/shp65,然后转化含有pAdeasy的大肠杆菌BJ5183中进行同源重组,提取含目的基因的腺病毒重组体质粒,经PacⅠ酶切线性化后用脂质体转染293细胞,包装成重组腺病毒Ad-shp65,扩增、纯化,并对病毒滴度进行检测。利用得到的重组腺病毒感染小鼠血管瘤细胞EOMA,采用RT-PCR和荧光定量PCR检测感染前后NF-κ Bp65表达水平的变化,观察Ad-shp65对EOMA中NF-κ Bp65表达的影响。结果成功构建NF-κB p65 siRNA腺病毒载体,该载体可明显抑制EOMA细胞中NF-κ Bp65的表达。结论构建的Ad-shp65腺病毒能有效抑制NF-κ Bp65基因在小鼠血管瘤细胞中的表达,为研究异种移植延迟性排斥反应提供了新的方法。 Objective To construct an adenovirus vector for efficient delivery of NF-κBp65 siRNA and to investigate its effect on EOMA cells. Methods After digestion with NotⅠand SalⅠ,the H1 promoter and NF-κ Bp65 shRNA were cloned into the shuttle vector. Once constructed,the shuttle vector is linearized with Pme Ⅰ and transformed into BJ5183 cells pretransformed with the pAdEasy plasmid. Transformants are selected for kanamy-cin resistance,and recombinants are subsequently identified by restriction digestion. Purifie...
出处 《中国血液流变学杂志》 CAS 2008年第3期313-316,共4页 Chinese Journal of Hemorheology
基金 国家自然科学基金资助项目(No.30671983)
关键词 SIRNA NF-κ BP65 腺病毒 EOMA细胞 siRNA NF-κBp65 adenovirus vector EOMA
  • 相关文献

参考文献10

  • 1[1]Elbashir SM,Lendeekle W,Tuschl T.RNA interference is mediated by 21-and 22-nucleotide RNAs[J].Genes Dev,2001,15(2):188-200.
  • 2[2]Bach FH,Robson SC,Ferran C,et al.Endothelial cell activation and thromboregulation during xenograft rejection[J].Immunol Rev,1994,141:5-30.
  • 3[3]Robson SC,Candinas D,Hancock WW,et aI.Role of endothelial cells in transplantation[J].lnt Arch Allergy Immunol,1995,106(4):305-322.
  • 4[4]Beg AA,Finco TS,Nantermet PV,et al.Tumor necrosis factor and interleukin 1 lead to phosphorylation and loss of I kappa B-alpha:a mechanism for NF-kappaB activation[J].Mol Cell Biol,1993,13(6):3301-3310.
  • 5[5]Henkel T,Machleidt T,Alkalay I,et al.Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B[J].Nature,1993,365(6442):182-185.
  • 6[6]Tak PP,Firestein GS.NF-kappa B:a key role in inflammatory diseases[J].J Clin Invest,2001,107(1):7-11.
  • 7[7]Baldwin AS JR.Series introduction:the transcription factor NF-kappa B and human disease[J].J Clin Invest,2001,107(1):3-6.
  • 8[8]Barnes P J,Karin M.Nuclear factor-KB-A pivotal trancription factor in chronic inflammatory diseases[J].N Engl J Med,1997,336(15):1066-1071.
  • 9[9]Makarov SS.NF-kappaB as a therapeutic target in chronic inflammation:recent advances[J].Mol Med Today,2000,6(11):441-448.
  • 10[10]He TC,Zhou S,da Costa LT,et al.A simplified system for generating recombinant adenoviruses[J].Proc Natl Acad Sci U S A,1998,95(5):2509-2514.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部